Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plantis is an Israeli medical cannabis company focused on cultivating and marketing medical-grade cannabis products. Founded in 2020, the company operates an integrated breeding, flowering, cultivation, R&D, and office complex in Moshav Keshet in the Golan Heights. Plantis emphasizes environmentally advantaged outdoor cultivation combined with advanced agricultural technology, and it operates under Israeli IMC-G.A.P and international G.A.C.P cultivation standards. The company appears to be commercially active in the Israeli medical cannabis market and has expanded its portfolio through a licensing agreement for proprietary cannabis varieties from Canonic, a subsidiary of Evogene. Its products are positioned around therapeutic cannabis use cases such as pain relief, muscle relaxation, and mood elevation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plantis.